Welcome to the official website of Unipharm pharmaceutical industry Co., Ltd.!
Focus on research and development of new active pharmaceutical ingredients, pharmaceutical intermediates, APIs and other specialty chemicals
Pharmaceutical Intermediates Heterocyclic Block Organic Block
Home> Pharmaceutical Intermediates>Antineoplastic Agents> Tevanitide Intermediate
Tivanitil Is A New Highly Selective C-Met Tyrosine Kinase Inhibitor, Ki 355 Nm, Which Is An Experimental Small Molecule Anticancer Drug. This Is A Bisindole Maleimide, Which Binds To Dephosphorylated Met Kinase In Vitro. Tmt Is A Growth Factor Receptor.
No data